REL and B-cell chronic lymphocytic leukemia: C-Rel gene amplification or persistent activation has been detected in many human B cell tumors, including diffuse large B cell lymphomas, primary mediastinal lymphoma, CLL, and multiple myeloma, as well as in some solid tumors [29]–[45].